BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15936566)

  • 21. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
    Bacci G; Forni C; Longhi A; Ferrari S; Mercuri M; Bertoni F; Serra M; Briccoli A; Balladelli A; Picci P
    J Surg Oncol; 2007 Aug; 96(2):118-23. PubMed ID: 17577221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
    Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
    J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
    Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
    Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
    Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
    Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.
    Bacci G; Ferrari S; Longhi A; Forni C; Bertoni F; Fabbri N; Zavatta M; Versari M
    J Chemother; 2001 Feb; 13(1):93-9. PubMed ID: 11233808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results after combined modality treatment for non-metastatic osteosarcoma.
    Aparicio J; Segura A; Montalar J; Garcerá S; Oltra A; Santaballa A; Yuste A; Pastor M; Munárriz B
    Med Oncol; 1999 Dec; 16(4):255-60. PubMed ID: 10618688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response.
    Ferrari S; Mercuri M; Picci P; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Longhi A; Rimondini S; Donati D; Manfrini M; Ruggieri P; Biagini R; Bacci G
    Tumori; 1999; 85(6):458-64. PubMed ID: 10774566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999.
    Bacci G; Ferrari S; Mercuri M; Longhi A; Fabbri N; Galletti S; Forni C; Balladelli A; Serra M; Picci P
    Acta Orthop; 2007 Jun; 78(3):377-84. PubMed ID: 17611853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telangiectatic osteogenic sarcoma of the extremities. Results in 17 patients treated with neoadjuvant chemotherapy.
    Pignatti G; Bacci G; Picci P; Dallari D; Bertoni F; Bacchini P; Capanna R
    Clin Orthop Relat Res; 1991 Sep; (270):99-106. PubMed ID: 1884565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th study.
    Bacci G; Ferrari S; Mercuri M; Longhi A; Capanna R; Tienghi A; Brach del Prever A; Comandone A; Cesari M; Bernini G; Picci P
    Acta Oncol; 1998; 37(1):41-8. PubMed ID: 9572653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.
    Berend KR; Pietrobon R; Moore JO; Dibernardo L; Harrelson JM; Scully SP
    J Surg Oncol; 2001 Nov; 78(3):162-70. PubMed ID: 11745799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities.
    Machak GN; Tkachev SI; Solovyev YN; Sinyukov PA; Ivanov SM; Kochergina NV; Ryjkov AD; Tepliakov VV; Bokhian BY; Glebovskaya VV
    Mayo Clin Proc; 2003 Feb; 78(2):147-55. PubMed ID: 12583525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
    Tunn PU; Reichardt P
    Onkologie; 2007 May; 30(5):228-32. PubMed ID: 17460416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
    Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
    Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
    Cancer; 1988 Apr; 61(7):1304-11. PubMed ID: 3125957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life.
    Bacci G; Ferrari S; Donati D; Longhi A; Bertoni F; Di Fiore M; Comandone A; Cesari M; Campanacci M
    Oncol Rep; 1998; 5(5):1259-63. PubMed ID: 9683847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Mercuri M; Ferrari S; Bertoni F; Gasbarrini A; Fabbri N; Cesari M; Forni C; Campanacci M
    J Chemother; 1998 Feb; 10(1):69-76. PubMed ID: 9531078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.